Allergy medication and exercise are closely linked for the millions of people in the UK who manage allergic conditions whilst leading active lives. Whether you take antihistamines for hay fever, inhaled corticosteroids for allergic asthma, or decongestants for nasal congestion, the medications you use can influence your physical performance, cardiovascular responses, and safety during activity. Equally, uncontrolled allergy symptoms can themselves limit exercise tolerance. This article explores how common allergy treatments interact with physical activity, how to exercise safely whilst on medication, and when to seek advice from a pharmacist, GP, or specialist.

How Allergy Medications Can Affect Physical Performance

Older antihistamines cause sedation and impair coordination, while decongestants can raise heart rate and blood pressure; second-generation antihistamines and intranasal corticosteroids have a more favourable profile for active individuals.

For many people in the UK, managing allergies is a daily necessity — but the medications used to control symptoms can have a meaningful impact on physical performance and exercise capacity. Understanding these effects is important for anyone who leads an active lifestyle, from recreational gym-goers to competitive athletes.

Some allergy medications, particularly older-generation antihistamines, are known to cause sedation and cognitive slowing, which can impair coordination, reaction time, and motivation to exercise. Even when drowsiness is not overtly felt, subtle reductions in alertness may affect performance during activities that require precision or rapid decision-making. It is worth noting that some second-generation antihistamines — particularly cetirizine — can also cause drowsiness in a minority of people. It is therefore advisable to assess how any antihistamine affects you personally before undertaking high-risk activities such as cycling on busy roads or contact sports.

Not sure if this is normal? Chat with one of our pharmacists →

Beyond sedation, certain medications can influence cardiovascular responses during exercise. Decongestants such as pseudoephedrine can raise heart rate and blood pressure, which may be a concern during high-intensity training. Pseudoephedrine should be avoided by people with uncontrolled hypertension or cardiovascular disease, and it can interact dangerously with monoamine oxidase inhibitors (MAOIs). If you are unsure whether a decongestant is appropriate for you, speak to a pharmacist or GP before use. Conversely, intranasal corticosteroids and second-generation antihistamines tend to have a more favourable side-effect profile and are less likely to interfere with physical output.

It is also worth noting that uncontrolled allergy symptoms themselves — such as nasal congestion, itchy eyes, or breathing difficulties — can significantly reduce exercise tolerance. In this context, appropriate allergy treatment may actually improve a person's ability to exercise comfortably, provided the medication chosen is well-suited to an active lifestyle.

Antihistamines, Steroids and Other Common Allergy Treatments

First-generation antihistamines impair alertness; second-generation options are preferred for active people. Intranasal corticosteroids are NICE first-line for persistent allergic rhinitis and are unlikely to affect exercise performance.

Allergy medications fall into several broad categories, each with distinct mechanisms of action and relevance to exercise.

Antihistamines are among the most widely used allergy treatments in the UK. They work by blocking H1 histamine receptors, thereby reducing symptoms such as sneezing, itching, and urticaria. First-generation antihistamines (e.g., chlorphenamine) cross the blood-brain barrier and commonly cause drowsiness, dry mouth, and impaired concentration — all of which can negatively affect exercise performance. Second-generation antihistamines (e.g., cetirizine, loratadine, fexofenadine) are considerably less sedating and are generally preferred for people who wish to remain physically active; however, cetirizine in particular may still cause drowsiness in some individuals, so personal response should be assessed before high-risk activities.

Intranasal corticosteroids (e.g., beclometasone, fluticasone) are anti-inflammatory agents that reduce mucosal swelling and are considered first-line treatment for persistent or moderate-to-severe allergic rhinitis by NICE. For mild or intermittent symptoms, a second-generation antihistamine may be sufficient. Inhaled corticosteroids are the mainstay preventer treatment within the stepwise management of asthma, as set out in NICE NG80 and the BTS/SIGN British guideline on asthma. When used as directed, both intranasal and inhaled corticosteroids have minimal systemic absorption and are unlikely to impair exercise performance. Oral corticosteroids carry greater systemic effects — including effects on metabolism, bone density, and cardiovascular function — and are not suitable for long-term use. They are not first-line treatment for acute anaphylaxis; adrenaline is the first-line intervention in that setting, as defined by the Resuscitation Council UK.

Leukotriene receptor antagonists such as montelukast are sometimes prescribed for allergic rhinitis or asthma. They work by blocking inflammatory mediators and are generally well tolerated. However, the MHRA has issued safety guidance (updated 2022) noting a risk of neuropsychiatric side effects — including mood changes, sleep disturbances, and behavioural effects — in some patients. These effects could indirectly affect motivation and wellbeing during exercise. Patients and carers should be counselled about these risks at the point of prescribing.

Experiencing these side effects? Our pharmacists can help you navigate them →

Other treatments include mast cell stabilisers (e.g., sodium cromoglicate) and allergen immunotherapy. Immunotherapy is a specialist-led treatment indicated for selected patients — for example, those with severe allergic rhinitis to pollens or venom allergy — following a careful risk–benefit assessment. It aims to reduce the underlying allergic response over time and may ultimately improve exercise tolerance in sensitised individuals.

Exercising Safely Whilst Taking Allergy Medication

Most people on allergy medication can exercise safely by choosing non-sedating antihistamines, using preventer inhalers consistently, warming up gradually, and checking decongestants and anti-doping status before competition.

With the right precautions, most people taking allergy medication can exercise safely and effectively. The key is to match the medication to your lifestyle and to be aware of how your body responds during physical activity.

If you are taking a first-generation antihistamine, it is advisable to avoid activities that require sharp reflexes or complex coordination until you know how the medication affects you. Scheduling exercise at a time when the sedative effect is likely to have worn off (e.g., the following morning if taken at night) can be a practical strategy. As noted above, even some second-generation antihistamines can cause drowsiness in certain individuals, so the same principle applies.

For those using inhaled corticosteroids or bronchodilators for allergic asthma or exercise-induced bronchoconstriction (EIB), it is important to:

• Ensure regular use of your preventer inhaler (inhaled corticosteroid) if one has been prescribed, as good day-to-day asthma control reduces the risk of EIB

• Warm up gradually (at least 10–15 minutes) to help reduce the risk of EIB

• If your GP or asthma nurse has advised it, take 2 puffs of your reliever inhaler (e.g., salbutamol) 10–15 minutes before exercise

• Carry your reliever inhaler with you during exercise at all times

• Check your inhaler technique regularly with a healthcare professional, and use a spacer if recommended

• Avoid exercising outdoors on high pollen days if pollen is a known trigger

• Stay well hydrated, particularly in warm or dry environments

People taking decongestants such as pseudoephedrine should be cautious about high-intensity cardiovascular exercise, given the potential for elevated heart rate and blood pressure. Those with hypertension, heart disease, or other cardiovascular conditions should seek pharmacist or GP advice before using decongestants. Pseudoephedrine should not be taken alongside MAOIs. It is also a prohibited substance in competition under the World Anti-Doping Agency (WADA) code above a urinary threshold of 150 micrograms per millilitre. Competitive athletes should check the status of any medication — including over-the-counter products — via UK Anti-Doping (UKAD) or the Global Drug Reference Online (Global DRO) tool before use, and seek advice from their team medical staff where available.

When choosing an environment for exercise, well-ventilated indoor settings or exercising outdoors when pollen counts are low can help reduce allergen exposure. Note, however, that indoor swimming pools may not be suitable for everyone: chloramines in pool water can irritate the airways of some people with asthma or airway sensitivity. If you find that swimming worsens your respiratory symptoms, discuss this with your GP or asthma nurse.

Exercise-Induced Allergic Reactions: What You Should Know

Exercise-induced anaphylaxis and food-dependent exercise-induced anaphylaxis are recognised conditions requiring specialist referral; affected individuals must carry a prescribed adrenaline auto-injector and call 999 immediately if a reaction occurs.

A distinct and important consideration is the phenomenon of exercise-induced allergic reactions, which range from mild urticaria to life-threatening anaphylaxis. These reactions are not caused by allergy medication but are triggered by exercise itself, sometimes in combination with specific foods or environmental factors.

Exercise-induced urticaria and anaphylaxis (EIAn) is a recognised clinical condition in which physical exertion triggers the release of histamine and other inflammatory mediators from mast cells. Symptoms can include:

• Flushing, itching, and hives

• Swelling of the face, lips, or throat

• Difficulty breathing or wheezing

• Dizziness, nausea, or collapse

A related condition, food-dependent exercise-induced anaphylaxis (FDEIA), occurs when a specific food (commonly wheat or shellfish) is consumed within a few hours before exercise, with the combination triggering a severe allergic response that neither the food nor exercise would cause independently. People with suspected FDEIA should avoid their identified trigger food for at least 4–6 hours before exercise, and should also be aware that cofactors such as alcohol and non-steroidal anti-inflammatory drugs (NSAIDs) can increase the risk of a reaction. Specialist allergy referral is strongly recommended for assessment and management.

These conditions are distinct from exercise-induced bronchoconstriction (EIB), which primarily affects the airways and is more common in people with asthma or allergic rhinitis. EIB typically presents as coughing, wheezing, or chest tightness during or shortly after exercise.

If you have experienced any allergic symptoms during or after exercise, it is essential to seek medical evaluation. Individuals diagnosed with EIAn or FDEIA are typically advised to carry an adrenaline auto-injector (AAI) as prescribed — for example, an EpiPen or Jext — and to ensure that those around them are trained to use it. Where there is a known risk of exercise-induced anaphylaxis, exercising with an informed companion is strongly advisable.

1. In the event of a suspected anaphylactic reaction during exercise:
2. Administer intramuscular adrenaline using the prescribed AAI immediately
3. Call 999 without delay
4. Lie down with legs raised (unless breathing is difficult, in which case sit upright); do not stand or walk
5. A second dose of adrenaline may be given after 5–15 minutes if there is no improvement and a second AAI is available

These steps are consistent with Resuscitation Council UK guidance on the emergency treatment of anaphylaxis.

NHS and MHRA Guidance on Allergy Medication and Activity

The NHS recommends second-generation antihistamines for daytime use, and the MHRA highlights neuropsychiatric risks with montelukast and cautions against first-generation antihistamines in situations requiring alertness.

Both the NHS and the Medicines and Healthcare products Regulatory Agency (MHRA) provide relevant guidance that applies to allergy medication use in the context of physical activity.

The NHS advises that second-generation antihistamines such as loratadine and cetirizine are generally preferred over first-generation options for daytime use, because they are less likely to cause drowsiness that could impair daily activities — including exercise. The NHS also recommends that patients with allergic asthma follow a personalised asthma action plan developed with their GP or asthma nurse, which should include guidance on exercising safely.

The MHRA has issued specific safety communications relevant to active individuals. These include:

• A 2022 Drug Safety Update highlighting neuropsychiatric risks associated with montelukast, recommending that patients and carers are counselled about potential mood changes, sleep disturbances, and behavioural effects before and during treatment

• Ongoing guidance that first-generation antihistamines should not be used in situations requiring alertness, including driving and operating machinery — a caution that extends to many forms of exercise

• Reminders that oral corticosteroids should be used at the lowest effective dose for the shortest possible duration, given their systemic effects on metabolism, bone density, and cardiovascular function

For UK-licensed medicines, the primary sources of product-level safety information are the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL) available via the Electronic Medicines Compendium (EMC) at medicines.org.uk. Patients are encouraged to read the PIL supplied with their medication and to consult a healthcare professional if they have specific concerns about exercising whilst on treatment.

If you experience a suspected side effect from any allergy medication, you can report it directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. This applies to both prescription and over-the-counter medicines, and your report helps the MHRA monitor the ongoing safety of medicines used in the UK.

When to Speak to Your GP or Pharmacist

Consult a pharmacist for questions about drowsiness, dose timing, or interactions; see your GP if symptoms are uncontrolled, you have had an allergic reaction during exercise, or side effects are affecting your quality of life.

Knowing when to seek professional advice is an important part of managing allergy medication safely alongside an active lifestyle. Many concerns can be addressed by a community pharmacist without the need for a GP appointment, but certain situations warrant more urgent attention.

Speak to your pharmacist if:

• You are unsure whether your current antihistamine is likely to cause drowsiness or affect your exercise performance

• You wish to switch from a first-generation to a second-generation antihistamine

• You are taking over-the-counter allergy medication alongside prescribed treatments and want to check for interactions

• You have questions about the timing of doses relative to exercise sessions

• You want to check whether a decongestant is appropriate given your medical history

Contact your GP if:

• Your allergy symptoms are not adequately controlled despite medication, and this is limiting your ability to exercise

• You have experienced any allergic reaction during or after exercise, including hives, swelling, or breathing difficulties — your GP may refer you to a specialist allergy clinic for further assessment

• You are experiencing side effects from your allergy medication — such as mood changes, palpitations, or persistent fatigue — that are affecting your quality of life or exercise capacity; you can also report these via the MHRA Yellow Card scheme

• You have concerns about your asthma management in relation to exercise, including possible exercise-induced bronchoconstriction

For urgent advice that is not immediately life-threatening, call NHS 111, who can direct you to the most appropriate service.

Competitive athletes should check the status of all medications — including over-the-counter products — using the UKAD website or the Global DRO tool before use, and consult their team medical staff or GP for guidance on anti-doping compliance.

Seek emergency medical help (call 999) immediately if you or someone else develops signs of anaphylaxis during or after exercise, including throat swelling, severe breathing difficulty, or loss of consciousness. Administer the prescribed adrenaline auto-injector without delay and do not wait to see if symptoms improve.

With appropriate medical support and the right choice of medication, the vast majority of people with allergies can continue to exercise safely and enjoy the well-established physical and mental health benefits of regular activity.

Frequently Asked Questions